Aboian E, Winter D C, Metcalf D R, Wolff B G
Department of Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Dis Colon Rectum. 2006 Oct;49(10):1564-8. doi: 10.1007/s10350-006-0669-0.
Perineal hernias are infrequent complications of abdominoperineal operations with estimated historic prevalences (from the era where the perineal wound was left open) ranging from 0.6 to 7 percent. The purpose of this study was to identify the modern prevalence of postoperative perineal hernias, factors that may contribute to their development, and examine the methods of repair.
The Mayo Clinic patient database (1990-2000) was interrogated for the following data identifiers: incisional hernia, perineal hernia, abdominoperineal resection, proctocolectomy, and partial or total pelvic exenteration. All surviving patients were followed up to December 2005. The retrieved patient data was retrospectively analyzed.
Of a total of 3,761 patients who underwent abdominoperineal resection (including nonrestorative proctocolectomy and pelvic exenteration) during the study period, 8 developed a perineal hernia (5 females). The median age at hernia presentation was 76 (range, 69-84) years, representing a median interval of 22 (range, 1-60) months from the original operation. All were smokers (> or =15 pack years) and five had received chemoradiotherapy for their original diagnosis. The commonest prevalence was found in patients who had undergone abdominoperineal resection (5/1,266) or pelvic exenteration (2/1,334). Only 1 of 1,161 patients developed a perineal hernia after proctocolectomy despite most being on perioperative immunosuppression for inflammatory bowel disease. Abdominal exploration and repair was performed in four patients whereas four underwent perineal repair (2 of each with mesh). None have recurred with a median follow-up of 36 (range, 6-60) months.
Perineal hernias are rare complications of abdominoperineal surgery with a more common prevalence after cancer operations. Smoking and chemoradiotherapy, but not corticosteroid immunosuppression, may be factors. The abdominal approach has advantages over the perineal approach, but both are suitable with good medium-term results.
会阴疝是腹会阴手术罕见的并发症,据估计历史患病率(来自会阴伤口敞开的时代)在0.6%至7%之间。本研究的目的是确定术后会阴疝的现代患病率、可能导致其发生的因素,并研究修复方法。
查询梅奥诊所患者数据库(1990 - 2000年)以获取以下数据标识符:切口疝、会阴疝、腹会阴切除术、直肠结肠切除术以及部分或全盆腔脏器清除术。所有存活患者随访至2005年12月。对检索到的患者数据进行回顾性分析。
在研究期间接受腹会阴切除术(包括非保留性直肠结肠切除术和盆腔脏器清除术)的3761例患者中,8例发生了会阴疝(5例女性)。疝出现时的中位年龄为76岁(范围69 - 84岁),从初次手术到疝出现的中位间隔时间为22个月(范围1 - 60个月)。所有患者均为吸烟者(≥15包年),5例因初始诊断接受过放化疗。最常见于接受腹会阴切除术(5/1266)或盆腔脏器清除术(2/1334)的患者。在1161例直肠结肠切除术后患者中,只有1例发生会阴疝,尽管大多数患者因炎症性肠病在围手术期接受免疫抑制治疗。4例患者进行了腹部探查和修复,4例接受了会阴修复(各2例使用补片)。中位随访36个月(范围6 - 60个月),均无复发。
会阴疝是腹会阴手术的罕见并发症,在癌症手术后更为常见。吸烟和放化疗可能是相关因素,但皮质类固醇免疫抑制不是。腹部手术方式比会阴手术方式有优势,但两种方式都适用且中期效果良好。